Fuchs CS, Doi T, Jang RW-J, et al. KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer. J Clin Oncol. 2017;35 (suppl; abstr 4003).
Neoadjuvante immuuntherapiecombinatie inzetbaar en effectief bij blaaskanker
okt 2020 | Immuuntherapie, Uro-oncologie